Quanta Pharma 5-Amino-1MQ 50mg

is a pharmaceutical-grade

selective NNMT inhibitor

(nicotinamide N-methyltransferase), a small molecule compound researched for its effects on metabolic regulation, fat metabolism, NAD+ preservation, and cellular energy balance. This lyophilised vial from

Quanta Pharma

offers researchers a high-purity compound for advanced studies in adipogenesis, obesity models, longevity pathways, and mitochondrial function. Independent Analiza Białek testing confirms the finished vial at 52.53mg content and 99% purity. Available for

UK delivery

with fast dispatch.

Analiza Białek Finished Product Verified

Independent testing of the sealed vial by a leading EU laboratory

Actual Content

Label Claim

Accuracy

Purity

Sample:

Sealed production vial  |

Order:

100014035  |

Tested:

April 2026  |

Verification Key:

H4A29M5E

Quanta Pharma 5-Amino-1MQ Specifications

Compound

5-Amino-1MQ

Also Known As

5-Amino-1-methylquinolinium

Dosage

50mg/vial

Class

NNMT Inhibitor

Form

Orange Powder

Molecule Type

Small Molecule

Storage

2-8°C, Dry

Research Route

Oral

5-Amino-1MQ 50mg

Quanta Pharma

Quanta Pharma 5-Amino-1MQ Research Benefits

NNMT inhibition

: Selectively blocks nicotinamide N-methyltransferase, the enzyme responsible for degrading NAD+ precursors and SAM methyl donors

Reduced adipogenesis

: Preclinical research demonstrates significant reduction in fat cell formation and white adipose tissue accumulation

NAD+ preservation

: By inhibiting NNMT, cellular nicotinamide is conserved and available for NAD+ synthesis, supporting mitochondrial function

Metabolic regulation

: Investigated for effects on insulin sensitivity, glucose metabolism, and cellular energy expenditure

Anti-obesity research

: Studies in diet-induced obesity models have shown reductions in body weight and adipose mass without affecting food intake

Orally bioavailable

: As a small molecule rather than a peptide, it maintains activity via oral administration in research protocols, avoiding the need for injection

How Quanta Pharma 5-Amino-1MQ Works

5-Amino-1MQ

By inhibiting NNMT,

Quanta Pharma 5-Amino-1MQ

Additionally,

Quanta Pharma 5-Amino-1MQ

has drawn significant interest in longevity research, given the central role NAD+ plays in sirtuin activity, mitochondrial biogenesis, and DNA repair. Its small molecule structure makes it a practical orally-administered research tool, setting it apart from the injectable peptides that dominate this research space.

Quanta Pharma 5-Amino-1MQ vs Traditional NAD+ Precursors

While NAD+ precursors like NMN and NR aim to raise NAD+ levels by supplying more raw material,

5-Amino-1MQ

takes the opposite approach: it prevents NAD+ precursors from being destroyed in the first place. This makes

Quanta Pharma 5-Amino-1MQ

a mechanistically distinct research tool, particularly suited to studies focused on adipose tissue metabolism, where NNMT expression is highest. Researchers studying obesity, metabolic syndrome, or adipocyte biology often prefer NNMT inhibition over simple precursor supplementation because the effect is concentrated where it matters most.

Why Choose Quanta Pharma 5-Amino-1MQ?

Quanta Pharma

is renowned for producing pharmaceutical-grade research compounds with exceptional purity and accurate dosing. The 50mg vial of

Quanta Pharma 5-Amino-1MQ

⚠️ FOR LABORATORY RESEARCH USE ONLY

NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE

Safety Classification:

For use by qualified research personnel only. Keep detailed records of usage and storage as per UK research regulations.

Legal Notice:

This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.